Save your place

Sign in to WhoBought

Please try again later.

Atossa Therapeutics, Inc. (ATOS) institutional ownership

Latest close $2.30 Jul 24, 2026
Market cap$106M 52-week range SectorHealthcare
Funds holding · Q1 2026
32
reported ATOS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
31 buyers · 1 sellers

Atossa Therapeutics, Inc. (ATOS) price and institutional activity

Dates

Q1 2026

$0 bought by 31 investors
VanguardAmeriprise Financial Inc +29 more
$0 sold by 1 investors
Marshall Wace, LLP
Bought Sold Totals per quarter; hover a bar for the names.

Atossa Therapeutics, Inc. (ATOS) institutional activity · 32

Investor Type Est. change Change Δ Own Date
Vanguard · New
Change +404K Date Q1 2026
Vanguard New· Q1 2026 +404K Q1 2026
Ameriprise Financial Inc · New
Change +255K Date Q1 2026
Ameriprise Financial Inc New· Q1 2026 +255K Q1 2026
BlackRock · New
Change +133K Date Q1 2026
BlackRock New· Q1 2026 +133K Q1 2026
Renaissance Technologies LLC New· Q1 2026 +109K Q1 2026
Geode · New
Change +97K Date Q1 2026
Geode New· Q1 2026 +97K Q1 2026
UBS Group AG · New
Change +92K Date Q1 2026
UBS Group AG New· Q1 2026 +92K Q1 2026
Millennium Management LLC · New
Change +67K Date Q1 2026
Millennium Management LLC New· Q1 2026 +67K Q1 2026
State Street · New
Change +40K Date Q1 2026
State Street New· Q1 2026 +40K Q1 2026
Marshall Wace, LLP · Exited
Change −28K Δ Own −100.0% Date Q1 2026
Marshall Wace, LLP Exited· Q1 2026 −28K −100.0% Q1 2026
Northern Trust · New
Change +19K Date Q1 2026
Northern Trust New· Q1 2026 +19K Q1 2026
Morgan Stanley · New
Change +16K Date Q1 2026
Morgan Stanley New· Q1 2026 +16K Q1 2026
Jones Financial Companies Lllp · New
Change +2K Date Q1 2026
Jones Financial Companies Lllp New· Q1 2026 +2K Q1 2026
Tower Research Capital LLC (trc) · New
Change +863 Date Q1 2026
Tower Research Capital LLC (trc) New· Q1 2026 +863 Q1 2026
Royal Bank of Canada · New
Change +644 Date Q1 2026
Royal Bank of Canada New· Q1 2026 +644 Q1 2026
Group One Trading LLC · New
Change +609 Date Q1 2026
Group One Trading LLC New· Q1 2026 +609 Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 32

Famous investor activity in Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics, Inc. (ATOS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Steinhart Richard I. · Director Grant (A) 10K
Owned 10K Trade date May 12, 2026 Filed date May 14, 2026
Steinhart Richard I. Director Grant (A) 10K 10K May 12, 2026 May 14, 2026
Chen Shu-Chih · Director Grant (A) 10K
Owned 10K Trade date May 12, 2026 Filed date May 14, 2026
Chen Shu-Chih Director Grant (A) 10K 10K May 12, 2026 May 14, 2026
Remmel H. Lawrence · Director Grant (A) 10K
Owned 11K Trade date May 12, 2026 Filed date May 14, 2026
Remmel H. Lawrence Director Grant (A) 10K 11K May 12, 2026 May 14, 2026
Finn Jonathan · Director Grant (A) 10K
Owned 12K Trade date May 12, 2026 Filed date May 14, 2026
Finn Jonathan Director Grant (A) 10K 12K May 12, 2026 May 14, 2026
Galli Stephen J. · Director Grant (A) 10K
Owned 10K Trade date May 12, 2026 Filed date May 14, 2026
Galli Stephen J. Director Grant (A) 10K 10K May 12, 2026 May 14, 2026
Cigler Tessa · Director Grant (A) 10K
Owned 10K Trade date May 12, 2026 Filed date May 14, 2026
Cigler Tessa Director Grant (A) 10K 10K May 12, 2026 May 14, 2026
Quay Steven C. · Director, Officer Grant (A) 65K
Owned 88K Trade date Mar 27, 2026 Filed date Mar 31, 2026
Quay Steven C. Director, Officer Grant (A) 65K 88K Mar 27, 2026 Mar 31, 2026
Daniel Mark James · Officer Grant (A) 63K
Owned 63K Trade date Mar 26, 2026 Filed date Mar 30, 2026
Daniel Mark James Officer Grant (A) 63K 63K Mar 26, 2026 Mar 30, 2026
Quay Steven C. · Director, Officer 2 operations 1.3M
Price $0.60 Owned 950K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Quay Steven C. Director, Officer 2 operations $0.60 1.3M 950K Jan 20, 2026 Jan 22, 2026
Daniel Mark James · Officer Grant (A) 578K
Owned 578K Trade date Oct 14, 2025 Filed date Oct 21, 2025
Daniel Mark James Officer Grant (A) 578K 578K Oct 14, 2025 Oct 21, 2025
10 of 10

Atossa Therapeutics, Inc. (ATOS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 9.7M
% of shares outstanding 7.7% Filing date Nov 8, 2024
Blackrock, Inc. 9.7M 7.7% Nov 8, 2024
Cvi Investments, Inc. 7.8M
% of shares outstanding 5.8% Filing date Feb 14, 2022
Cvi Investments, Inc. 7.8M 5.8% Feb 14, 2022
Vanguard Group Inc 7.0M
% of shares outstanding 5.5% Filing date Feb 9, 2022
Vanguard Group Inc 7.0M 5.5% Feb 9, 2022
Vanguard Group Inc 5.8M
% of shares outstanding 4.5% Filing date Jul 29, 2025
Vanguard Group Inc 5.8M 4.5% Jul 29, 2025
Cvi Investments, Inc. 5.7M
% of shares outstanding 4.3% Filing date Feb 7, 2025
Cvi Investments, Inc. 5.7M 4.3% Feb 7, 2025
BlackRock Inc. 3.6M
% of shares outstanding 2.8% Filing date Jul 8, 2022
BlackRock Inc. 3.6M 2.8% Jul 8, 2022
Empery Asset Management, LP 1.3M
% of shares outstanding 1.0% Filing date Jan 13, 2022
Empery Asset Management, LP 1.3M 1.0% Jan 13, 2022
7 of 7

Atossa Therapeutics, Inc. (ATOS) ownership FAQ

Who owns ATOS?

32 reporting institutions disclosed ATOS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.